Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

76 results about "Human ige" patented technology

Detecting kit for specific IgE antibody of food allergen as well as preparation and detecting methods of detecting kit

The invention belongs to the technical field of biology and particularly relates to a detecting kit for a specific IgE antibody (quantitative) of a food allergen as well as preparation and detecting methods of the detecting kit. The detecting kit is used for quantitatively detecting the content of the specific IgE antibody (quantitative) of the food allergen in human serum in vitro. The detecting kit for the specific IgE antibody of the food allergen contains the following components: a magnetic separation reagent, an allergen reagent, an enzyme reactant, a calibrated product, a quality control product, a concentrated cleaning solution and a substrate solution, wherein the magnetic separation reagent contains magnetic particles on which human IgE antibodies are coated, and the allergen reagent contains a biotin-labeled specific allergen. The detecting method of the detecting kit for the specific IgE antibody of the food allergen is realized by combining a chemiluminescence immune assay technology and a magnetic particle separation technology, and meanwhile, an enzyme-free capturing method is adopted, so that the detecting method has the advantages of convenience in operation, high sensitivity, good accuracy, high speed and no pollution.
Owner:HANGZHOU AOMIN BIOLOGICAL TECH CO LTD

Method of anaphylactogen screening

The invention is an allergen screening method, comprising the steps of: a. taking removable ELISA plate stripe as allergen screening carrier, and coating common allergens in ELISA plate holes; b. adding human serum into the ELISA plate stripe to make IgE antibodies in the serum specifically bind with the allergens, and then adding in biotin-labeled anti-human IgE to specifically form combination; c. successively adding in streptavidin-Horse Radish Peroxidase (streptavidin-HRP) and using biotin-avidin specific binding to form compound; d. finally adding in allergen color developing agent, and under the action of HRP, making the color developing agent change color, and determining the concentration of IgE antibodies in the sample according to the shade of color. And it is simple to operate and has accurate result and low cost.
Owner:深圳市博卡生物技术有限公司

Kit and method for detecting specific allergen antibody IgE in high-sensitivity manner

ActiveCN104237527AReduce dosageSuitable for high-throughput detectionBiological testingBiotin-streptavidin complexSerum ige
The invention provides a kit and a method for detecting specific allergen antibody IgE in a high-sensitivity manner. The kit mainly comprises a fiber material membrane provided with allergen protein to be detected, double biotin-streptavidin optimized liquid, a biotin coupled anti-human IgE antibody, biotin or streptavidin marked polymerase, and a substrate color developing agent corresponding to polymerase in a curing manner; the kit can qualitatively or semi-quantitatively detect the concentration of the specific allergen antibody IgE in human serum or plasma rapidly in the high-sensitivity manner, can screen dozens of allergens, is rapid and accurate, and is suitable for high-throughput testing, and a relatively small quantity of samples are used.
Owner:ZHEDA DIXUN BIO GENE ENG

Displaying native human IgE neutralizing FceRla-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold

Vaccine displaying native antigenic loops of immunoglobulin E is critical for eliciting neutralizing anti-IgE antibodies. The embodiment of the invention enables the display of native antigenic IgE receptor-contacting loops as IgE B-cell vaccines via three steps of constraining methods. The loops of multiple antigenic B-cell epitopes can be molecularly grafted in, and conformationally constrained by the energy favorable flanking beta (b)-stands, i.e., the super b-strands identified in this invention. The constrained loops can be further stabilized in replacing a selective loop within the cystine knot peptide. These dual constrained antigenic loops are then integrated onto thermostable protein scaffolds, folded in the oxidative milieu that provides further conformational constraint and high yield.
Owner:CHEN SWEY SHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products